<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WFOMRTU7</identifier><date>2017</date><creator>Fokter Dovnik, Nina</creator><creator>Takač, Iztok</creator><relation>documents/doc/W/URN_NBN_SI_doc-WFOMRTU7_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WFOMRTU7_001.txt</relation><format format_type="issue">1</format><format format_type="volume">51</format><format format_type="type">article</format><format format_type="extent">str. 65-73, VI</format><identifier identifier_type="DOI">10.1515/raon-2016-0024</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">5717567</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WFOMRTU7</identifier><language>eng</language><publisher publisher_location="[Zagreb]">Croatian Medical Association - Croatian Society of Radiology</publisher><publisher publisher_location="Ljubljana">Slovenian Medical Society - Section of Radiology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">adjuvantno sistemsko zdravljenje</subject><subject language_type_id="slv">dojke</subject><subject language_type_id="slv">prognoza</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">urokinazni aktivator plazminogena</subject><title>Prognostic significance of uPA/PAI-1 level, HER2 status, and traditional histologic factors for survival in node-negative breast cancer patients</title></Record>